Medicinal Chemistry Applet

Cp vs time - iv infusion

back to applets page

Introduction

Maintaining a steady-state plasma concentration (Css) is vital for a proper drug regimen.  The most direct method to achieving a desired Css is through iv infusion of a drug solution.  In this situation, the change in plasma concentration (dCp/dt) is affected by both the rate of infusion, kin, and the rate of elimination, kel (Equation 1).  [Note: Some discussions of this topic use different forms of kin.  In this treatment, the units on kin are mass/time.]  Integration of Equation 1 gives an expression that allows determination of Cp at any time during the infusion (eq. 2).

     (1)

     (2)

By Equation 2, as time approaches infinity, the exponential term approaches 0.  Cp approaches a constant value called the steady-state concentration, Css (eq. 3).  The same relationship may be derived from Equation 1 by setting dCp/dt to 0.  At this point Cp = Css.

     (3)

In a strict sense, Cp never reaches Css.  In practice, infusion of a drug for a period of four half-lives will achieve between 90 and 95% of the theoretical Css.  Since building Cp to near Css can take considerable time, an iv bolus may be used as a loading dose to "jump start" Cp.  Regardless of the status of the infusion or loading dose, once the infusion is halted, Cp will immediately begin to fall in standard, first-order fashion as determined by kel (Equation 4).

     (4)

Applet

This applet plots data for up to two different drugs.  For each drug, kin, kel, Vd, the length of time of the infusion, and the length of time to monitor Cp must be provided.  Data points for Cp vs time are plotted for the specified time period, and all varibles with time units should have the same unit of time measure.  If the units of kin are mg/h and Vd is in liters, then the units of Cp will be µg/mL. 

Cp vs time
parameter (units) Drug 1 (red) Drug 2 (blue) comment
kin (mg/h) rate of infusion
kel (h-1) elim. rate constant
Vd (L) distribution volume
time of infusion (h) time of infusion
time after infusion (h) time after infusion
calculation may be slow

Problem information

Vancomycin is an antibiotic that is only used to fight infections that show resistance to standard antibiotics.  These resistant bacteria are often called methicillin-resistant Staphylococcus aureus (MRSA) or "superbugs."  While the term MSRA did initially refer to methicillin-resistant strains, it now is generally used to describe any bacteria that show broad antibiotic resistance.  These bacteria are often found and transmitted in hospitals.  Vancomycin is not orally available and is frequently administered by intravenous infusion.

The pharmacokinetic parameters of vancomycin are shown below.

  • t1/2 = 5.6 h
  • kel = 0.12 h-1
  • Vd = 0.39 L/kg (27 L for a 70 kg patient)

Problems

  1. Goodman and Gilman's states that the peak concentration of vancomycin after a one hour infusion at a rate of 7.5 mg/kg/h or 1000 mg/h is 18.5 µg/mL.  Calculate the amount of drug infused at a rate of 7.5 mg/kg/h for a 70 kg patient in 1.0 h.  Use the applet to determine the which of the two infusion rates, if either, will give a peak concentration of 18.5 µg/mL after 1.0 h.
  2. Vancomycin can show ototoxicity, affecting hearing or inner ear balance, at concentrations of around 40 µg/mL.  Does either of the one-hour infusions at the rates in the first question lead to toxic levels of vancomycin?
  3. What rate of infusion of vancomycin would be required to achieve a Css of 20 µg/mL?  (Try different infusion rates in the applet to see the rate necessary to reach the desired concentration.)
  4. Although a steady-state concentration of vancomycin can eventually be achieved, how long does it take to reach 95% of the desired concentration of 20 µg/mL in question 3?  The problem of taking too long to reach a desired Css can be addressed through a "loading dose" in the form of an intravenous bolus.

Reference

Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th ed.; Hardman, J. G., Limbird, L. E., Eds.; McGraw-Hill: New York, 2001.

back to applets page